Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

UbcH10 a Major Actor in Cancerogenesis and a Potential Tool for Diagnosis and Therapy
Ivan Presta, Fabiana Novellino, Annalidia Donato, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 6, pp. 2041-2041
Open Access | Times Cited: 20

Showing 20 citing articles:

Applications of Iron Oxide Nanoparticles against Breast Cancer
Hessam Hosseinkazemi, Saeed Samani, Andrew O’Neill, et al.
Journal of Nanomaterials (2022) Vol. 2022, Iss. 1
Open Access | Times Cited: 34
UBE2S and UBE2C confer a poor prognosis to breast cancer via downregulation of Numb
Yanjing Guo, Xinyu Chen, Xiaowei Zhang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 11
UBE2C regulating the lung carcinoma progression via inhibiting ubiquitin-proteasomal degradation to increase MMP9 protein stability
Jie Zhao, Juanjuan Dai, Ning Zhou, et al.
Genes & Genomics (2025)
Closed Access
RBM15 relies on m6A modification to inhibit UBE2C, alleviating hippocampal neuronal injury by limiting microglial inflammation
Yuehong Wan, Kang Qin, Ji Zhang, et al.
Molecular and Cellular Neuroscience (2025), pp. 103996-103996
Closed Access
The Interconnection Between UbcH10, p53, and EGFR in Lung Cancer Cells and Their Involvement in Treatment Response
Cristina Quintavalle, Umberto Malapelle, Marco De Martino, et al.
Genes (2025) Vol. 16, Iss. 4, pp. 404-404
Open Access
Prognostic Value of Systemic Inflammatory Markers in Malignant Tumors of Minor Salivary Glands: A Retrospective Analysis of a Single Center
Maria Giulia Cristofaro, Francesco Ferragina, Samuel Staglianò, et al.
Cancers (2025) Vol. 17, Iss. 8, pp. 1373-1373
Open Access
Role of UBE2C in Brain Cancer Invasion and Dissemination
Stefani Domentean, Eunice Paisana, Rita Cascão, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15792-15792
Open Access | Times Cited: 9
Identification of transcriptome characteristics of granulosa cells and the possible role of UBE2C in the pathogenesis of premature ovarian insufficiency
Dan Liu, Xiaohong Guan, Wenqiang Liu, et al.
Journal of Ovarian Research (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 7
The Relationship Between UBE2C and AGGF1 Overexpression and Tumor Angiogenesis in Non-Small Cell Lung Cancer
Yufei Wang, Fan Shi, Run Tao, et al.
Cancer Management and Research (2021) Vol. Volume 13, pp. 5919-5930
Open Access | Times Cited: 17
Diverse roles of UBE2T in cancer (Review)
Nengqian Ma, Zhangzhan Li, Jingting Yan, et al.
Oncology Reports (2023) Vol. 49, Iss. 4
Open Access | Times Cited: 6
Genes of the Ubiquitin Proteasome System Qualify as Differential Markers in Malignant Glioma of Astrocytic and Oligodendroglial Origin
Jerry Vriend, Thomas Klonisch
Cellular and Molecular Neurobiology (2022) Vol. 43, Iss. 4, pp. 1425-1452
Open Access | Times Cited: 9
Function, mechanism and drug discovery of ubiquitin and ubiquitin-like modification with multiomics profiling for cancer therapy
Yanyu Jiang, Shuaishuai Ni, Biying Xiao, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 11, pp. 4341-4372
Open Access | Times Cited: 5
Combined Inhibition of UBE2C and PLK1 Reduce Cell Proliferation and Arrest Cell Cycle by Affecting ACLY in Pan-Cancer
Keying Liang, Qian Wang, Qiu Li, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15658-15658
Open Access | Times Cited: 4
Ubiquitin Proteasome Pathway Transcriptome in Epithelial Ovarian Cancer
Jerry Vriend, Mark W. Nachtigal
Cancers (2021) Vol. 13, Iss. 11, pp. 2659-2659
Open Access | Times Cited: 9
Targeting UBE2C for degradation by bioPROTACs based on bacterial E3 ligase
Jinpeng Wang, Min Zhang, Susheng Liu, et al.
Chinese Chemical Letters (2022) Vol. 34, Iss. 4, pp. 107732-107732
Closed Access | Times Cited: 6
Discovery of Benzodiazepine-Based Inhibitors of the E2 Enzyme UBCH10 from a Cell-Based p21 Degradation Screen
Benoit Pelletier, Stéphanie Duhamel, Guillaume Tambutet, et al.
ACS Chemical Biology (2023) Vol. 18, Iss. 5, pp. 1039-1046
Closed Access | Times Cited: 3
UBE2C promotes leptomeningeal dissemination and is a therapeutic target in brain metastatic disease
Eunice Paisana, Rita Cascão, Carlos Custódia, et al.
Neuro-Oncology Advances (2023) Vol. 5, Iss. 1
Open Access | Times Cited: 3
Expression significance of Emi1, UBCH10 and CyclinB1 in esophageal squamous cell carcinoma
Hui Li, Chenbo Yang, Kuisheng Chen, et al.
Pathology & Oncology Research (2023) Vol. 29
Open Access | Times Cited: 2
Development of a high-throughput assay to identify inhibitors of the ubiquitin-conjugating enzyme UBCH10
Patrick Cléroux, Laure Voisin, Sylvain Meloche
SLAS DISCOVERY (2022) Vol. 27, Iss. 4, pp. 266-271
Open Access | Times Cited: 3
Aberrant expression of UBE2C in endometrial cancer and its correlation to epithelial mesenchymal transition
Yan Zhang, Xueting Li, Yingying Gong, et al.
Medicine (2023) Vol. 102, Iss. 20, pp. e33834-e33834
Open Access | Times Cited: 1
UBE2C promotes leptomeningeal dissemination and is a therapeutic target in brain metastatic disease
Eunice Paisana, Rita Cascão, Carlos Custódia, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1

Scroll to top